Tag Archives: FDA

New Prostate Cancer Drug Approved by FDA

Posted on May 30, 2011 by wngai

Good news for patients with metastatic prostate cancer.  The FDA (US Food and Drug Administration) has approved Johnson & Johnson’s Zytiga (abiraterone) in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy.  Abiraterone … Continue reading →

Posted in Cancer, Prostate cancer | Tagged , , , , , , , , , | 1 Comment

FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer

Posted on May 30, 2011 by wngai

The US Food and Drug Administration (FDA) has approved everolimus (Afinitor) to treat patients with advanced pancreatic neuroendocrine tumors (pNETs).  pNETs is a rare, slow-growing form of pancreatic cancer.  In theUnited States, there are fewer than 1000 new pNET cases … Continue reading →

Posted in Cancer, Pancreatic Cancer | Tagged , , , , , , , , , , , , , | Comments Off on FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer